Skúšobnú verziu novej webovej stránky nájdete na beta.sukl.sk. Všetky aktuality, informácie a kompletný obsah sú zatiaľ prioritne dostupné na pôvodnej verzii webu.
en

PRODUCT DETAIL

Remsima 40 mg/ml koncentrát na infúzny roztok

Code 2231F
MA number EU/1/13/853/024
Product Form: con inf 2x8,75 ml/350 mg (liek.inj.skl.)
MA Status: E - Valid centralised marketing authorisation
Type of procedure: EU
MAH, country: Celltrion Healthcare Hungary Kft., Hungary
Therapeutic Class: 59 - IMMUNOPRAEPARATA
ATC:
L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
L04 Immunosuppressants
L04A Immunosuppressants
L04AB Tumor necrosis factor alpha (TNF-alpha) inhibitors
L04AB02 Infliximab
Shelf life: 48
Route of admin.: Intravenous use
Prescription Status: Medicinal product subject to restricted medical prescription.
Legal basis: Article 10(4) similar biological application
MA issued: 10.09.2013
SmPC + PL: European Medicines Agency's database
Safety feature Yes
Data update: 16.12.2025
eu-flag.png sk-flag.png